The main conclusion from this study is that patients with arthralgia who develop arthritis have changes in circulating lymphocyte subsets, starting with a decrease in CD8+ cytotoxic T cells 24 months prior to arthritis development, followed by a decrease in the number of activated memory B cells 12 months prior to disease onset. The gene discussed is CD8A; the disease is Arthralgia.